35.94
price up icon4.23%   1.46
after-market Dopo l'orario di chiusura: 36.39 0.45 +1.25%
loading
Precedente Chiudi:
$34.48
Aprire:
$34.58
Volume 24 ore:
952.26K
Relative Volume:
0.85
Capitalizzazione di mercato:
$3.37B
Reddito:
-
Utile/perdita netta:
$-115.88M
Rapporto P/E:
-26.82
EPS:
-1.34
Flusso di cassa netto:
$-104.72M
1 W Prestazione:
+4.33%
1M Prestazione:
+26.55%
6M Prestazione:
+84.12%
1 anno Prestazione:
+433.23%
Intervallo 1D:
Value
$33.64
$36.09
Intervallo di 1 settimana:
Value
$32.32
$36.09
Portata 52W:
Value
$5.12
$36.66

Edgewise Therapeutics Inc Stock (EWTX) Company Profile

Name
Nome
Edgewise Therapeutics Inc
Name
Telefono
720-262-7002
Name
Indirizzo
1715 38TH ST, BOULDER
Name
Dipendente
97
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
EWTX's Discussions on Twitter

Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-05-01 Iniziato Truist Buy
2022-08-25 Downgrade Goldman Neutral → Sell
2022-04-13 Iniziato RBC Capital Mkts Outperform
2022-01-28 Iniziato Goldman Neutral

Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie

pulisher
Nov 03, 2024

abrdn plc Purchases Shares of 256,645 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Nov 03, 2024
pulisher
Oct 31, 2024

Edgewise Therapeutics shares maintain price target on positive data By Investing.com - Investing.com Australia

Oct 31, 2024
pulisher
Oct 27, 2024

Novo Holdings A S Sells 794,530 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Oct 27, 2024
pulisher
Oct 24, 2024

Moody Aldrich Partners LLC Makes New Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Oct 24, 2024
pulisher
Oct 17, 2024

Edgewise Therapeutics stock hits 52-week high at $35.34 - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

Edgewise Therapeutics stock hits 52-week high at $35.34 By Investing.com - Investing.com Canada

Oct 17, 2024
pulisher
Oct 16, 2024

Edgewise Therapeutics Inc (EWTX)’s Market Momentum: Closing Strong at 32.99, Up 3.68 - The Dwinnex

Oct 16, 2024
pulisher
Oct 16, 2024

Top investors say Edgewise Therapeutics Inc (EWTX) ticks everything they need - SETE News

Oct 16, 2024
pulisher
Oct 15, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 52-Week HighShould You Buy? - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Is it possible to buy Edgewise Therapeutics Inc(EWTX) shares at a good price now? - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

EWTX (Edgewise Therapeutics Inc) may reap gains as insiders became active recently - Knox Daily

Oct 14, 2024
pulisher
Oct 13, 2024

SG Americas Securities LLC Sells 34,544 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Oct 13, 2024
pulisher
Oct 13, 2024

Piper Sandler Increases Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $51.00 - Defense World

Oct 13, 2024
pulisher
Oct 11, 2024

Minimal stock impact anticipated for Edgewise Therapeutics stock even with potential CK miss - Investing.com Canada

Oct 11, 2024
pulisher
Oct 11, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Shares Up 4.5% Following Analyst Upgrade - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Price Target Raised to $51.00 at Piper Sandler - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

(EWTX) Technical Pivots with Risk Controls - Stock Traders Daily

Oct 10, 2024
pulisher
Oct 10, 2024

Edgewise Therapeutics Inc (EWTX) Stock: Navigating Drops and Gains - The InvestChronicle

Oct 10, 2024
pulisher
Oct 10, 2024

Chief Scientific Officer Russell Alan J sold 75,000 shares of Edgewise Therapeutics Inc [EWTX] - Knox Daily

Oct 10, 2024
pulisher
Oct 09, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Hits New 12-Month HighTime to Buy? - MarketBeat

Oct 09, 2024
pulisher
Oct 09, 2024

A look into Edgewise Therapeutics Inc (EWTX)’s deeper side - SETE News

Oct 09, 2024
pulisher
Oct 09, 2024

Financial Analysis: Edgewise Therapeutics Inc (EWTX)’s Ratios Unveil Key Insights - The Dwinnex

Oct 09, 2024
pulisher
Oct 08, 2024

Was there any good news for Edgewise Therapeutics Inc (EWTX) stock in the last session? - US Post News

Oct 08, 2024
pulisher
Oct 08, 2024

Dimensional Fund Advisors LP Buys 168,219 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

Edgewise Therapeutics, Inc. (EWTX): A Hot Stock to Buy Now - Yahoo Finance

Oct 07, 2024
pulisher
Oct 07, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down – Here’s What Happened - Defense World

Oct 07, 2024
pulisher
Oct 07, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap DownHere's What Happened - MarketBeat

Oct 07, 2024
pulisher
Oct 07, 2024

Edgewise Therapeutics Inc [EWTX] Insider Activity: An Update for Investors - Knox Daily

Oct 07, 2024
pulisher
Oct 07, 2024

Squarepoint Ops LLC Purchases 27,687 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

Oct 07, 2024
pulisher
Oct 05, 2024

Millennium Management LLC Purchases 613,251 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Oct 05, 2024
pulisher
Oct 04, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Trading 5.2% HigherStill a Buy? - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Edgewise Therapeutics (NASDAQ:EWTX) Trading 5.2% Higher – Still a Buy? - Defense World

Oct 04, 2024
pulisher
Oct 04, 2024

Hypertrophic Cardiomyopathy Market Expected to Experience - openPR

Oct 04, 2024
pulisher
Oct 04, 2024

Hypertrophic Cardiomyopathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing - Barchart

Oct 04, 2024
pulisher
Oct 04, 2024

Edgewise Therapeutics Insiders Sold US$2.6m Of Shares Suggesting Hesitancy - Simply Wall St

Oct 04, 2024
pulisher
Oct 03, 2024

Chief Scientific Officer Russell Alan J sale 75,000 shares of Edgewise Therapeutics Inc [EWTX] - Knox Daily

Oct 03, 2024
pulisher
Oct 01, 2024

Marshall Wace LLP Grows Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Dark Forest Capital Management LP Makes New $193,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society - StockTitan

Oct 01, 2024
pulisher
Oct 01, 2024

Marshall Wace LLP Boosts Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Oct 01, 2024
pulisher
Sep 30, 2024

Balance Sheet Breakdown: Edgewise Therapeutics Inc (EWTX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

How did Edgewise Therapeutics Inc (EWTX) fare last session? - US Post News

Sep 30, 2024
pulisher
Sep 30, 2024

The Potential Rise in the Price of Edgewise Therapeutics Inc (EWTX) following insiders activity - Knox Daily

Sep 30, 2024
pulisher
Sep 30, 2024

Novo Holdings A S Makes New $114.26 Million Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Sep 30, 2024
pulisher
Sep 29, 2024

Frazier Life Sciences Management L.P. Buys 427,500 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

Sep 29, 2024
pulisher
Sep 29, 2024

Frazier Life Sciences Management L.P. Acquires 427,500 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Sep 29, 2024
pulisher
Sep 25, 2024

Duchenne Muscular Dystrophy Treatment Drugs, Clinical Trials, Pipeline Insights and Companies 2024 - The Globe and Mail

Sep 25, 2024
pulisher
Sep 25, 2024

Analyst Think There's Still Time to Get in on Edgewise, Up 332% - sharewise

Sep 25, 2024
pulisher
Sep 25, 2024

Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge - Benzinga

Sep 25, 2024
pulisher
Sep 25, 2024

Edgewise Therapeutics Inc (EWTX)’s Market Momentum: Closing Strong at 25.92, Down -2.15 - The Dwinnex

Sep 25, 2024
pulisher
Sep 25, 2024

Analysts Think There's Still Time to Get in on Edgewise, Up 332% - MarketBeat

Sep 25, 2024

Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Edgewise Therapeutics Inc Azioni (EWTX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Russell Alan J
Chief Scientific Officer
Sep 20 '24
Option Exercise
0.18
75,000
13,500
87,719
Russell Alan J
Chief Scientific Officer
Sep 20 '24
Sale
28.27
75,000
2,120,101
12,719
MOORE JOHN R
General Counsel
Sep 20 '24
Option Exercise
0.71
50,000
35,500
53,252
MOORE JOHN R
General Counsel
Sep 23 '24
Option Exercise
0.71
20,922
14,855
24,174
MOORE JOHN R
General Counsel
Sep 20 '24
Sale
28.37
50,000
1,418,510
3,252
MOORE JOHN R
General Counsel
Sep 23 '24
Sale
27.63
20,922
578,064
3,252
Donovan Joanne M.
CMO
Sep 20 '24
Sale
28.29
7,162
202,603
14,538
Derakhshan Behrad
Chief Business Officer
Sep 20 '24
Option Exercise
1.93
42,068
81,191
57,189
Derakhshan Behrad
Chief Business Officer
Sep 20 '24
Sale
29.03
42,068
1,221,133
15,121
Carruthers R Michael
Chief Financial Officer
Sep 20 '24
Option Exercise
1.93
96,068
185,411
81,996
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):